Correlation Between RAMM Pharma and Canntab Therapeutics
Can any of the company-specific risk be diversified away by investing in both RAMM Pharma and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAMM Pharma and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAMM Pharma Corp and Canntab Therapeutics Limited, you can compare the effects of market volatilities on RAMM Pharma and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAMM Pharma with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAMM Pharma and Canntab Therapeutics.
Diversification Opportunities for RAMM Pharma and Canntab Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between RAMM and Canntab is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding RAMM Pharma Corp and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and RAMM Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAMM Pharma Corp are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of RAMM Pharma i.e., RAMM Pharma and Canntab Therapeutics go up and down completely randomly.
Pair Corralation between RAMM Pharma and Canntab Therapeutics
If you would invest 1.60 in Canntab Therapeutics Limited on August 29, 2024 and sell it today you would lose (1.59) from holding Canntab Therapeutics Limited or give up 99.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 29.44% |
| Values | Daily Returns |
RAMM Pharma Corp vs. Canntab Therapeutics Limited
Performance |
| Timeline |
| RAMM Pharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Canntab Therapeutics |
RAMM Pharma and Canntab Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RAMM Pharma and Canntab Therapeutics
The main advantage of trading using opposite RAMM Pharma and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAMM Pharma position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.| RAMM Pharma vs. City View Green | RAMM Pharma vs. Speakeasy Cannabis Club | RAMM Pharma vs. Pure Harvest Cannabis | RAMM Pharma vs. Ravenquest Biomed |
| Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |